title: Biochemical and immunohistochemical characterisation of mucins in 8 cases of colonic disease--a pilot study.
abstract: OBJECTIVE
  To characterise mucins in cancer of the colon and compare these with controls using stringent biochemical measures to avoid endogenous proteolysis.
  
  
  METHODS
  Crude mucus scrapings were collected from 12 specimens obtained by colectomy. Specimens from 3 traumatic colectomies and 1 sigmoid volvulus were used as controls, and compared with 6 specimens from colons resected for adenocarcinoma and 2 irradiated colons.
  
  
  METHODS
  The median age of the 4 female patients was 76 years (range 49 - 82 years), and of the 8 male patients 46.5 years (range 16 - 74 years).
  
  
  CONCLUSIONS
  The crude mucus scrapings in the 9 specimens ranged in weight from 353 mg to 7 697 mg (median 4 928 mg). The median of purified mucin in the 9 specimens was 0.72 microg/mg wet weight of scraped material. Eight samples gave non-extractable pellet material, and were treated with DTT to reduce disulphide bonds for further analysis. One of these 8 pellets was resistant to reduction and had to be digested with papain before analysis. Only 5 of these pellets had mucin. Gel filtration and SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) analysis revealed different populations of mucin based on size and extent of degradation. Western blotting and immunohistochemical analysis confirmed the presence of MUC2 in all samples, MUC5AC in 2 and MUC5B in 5 diseased specimens. Immunohistochemical analysis showed that there was no MUC1 in the normal specimens, MUC1 apoprotein (MUC1 core) in 2 cancer specimens and MUC1 in 1 cancer specimen. Histochemical analysis showed that normal tissue expressed neutral and acidic mucins and diseased specimens predominantly expressed acidic mucins. The electrophoretic behaviour of MUC2 in sigmoid volvulus was different from that in cancer of the colon.
authors.affiliation: Department of Surgery, University of Cape Town.
authors.forename: N
authors.initials: N
authors.lastname: Chirwa
authors.forename: A
authors.initials: A
authors.lastname: Mall
authors.forename: M
authors.initials: M
authors.lastname: Tyler
authors.forename: B
authors.initials: B
authors.lastname: Kavin
authors.forename: P
authors.initials: P
authors.lastname: Goldberg
authors.forename: J E J
authors.initials: JE
authors.lastname: Krige
authors.forename: Z
authors.initials: Z
authors.lastname: Lotz
authors.forename: D
authors.initials: D
authors.lastname: Kahn
authors.forename: D
authors.initials: D
authors.lastname: Govender
authors.forename: A
authors.initials: A
authors.lastname: Hunter
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002850:Chromatography, Gel; D003082:Colectomy; D003106:Colon / Q000276:immunology / Q000473:pathology*; D003108:Colonic Diseases / Q000276:immunology / Q000503:physiopathology* / Q000601:surgery; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D055271:Mucin 5AC; D018396:Mucin-1; D055262:Mucin-2; D055257:Mucin-5B; D009077:Mucins / Q000276:immunology*; D010865:Pilot Projects
chemical_list: C524625:MUC2 protein, human; C524678:MUC5AC protein, human; C524578:MUC5B protein, human; D055271:Mucin 5AC; D018396:Mucin-1; D055262:Mucin-2; D055257:Mucin-5B; D009077:Mucins